Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Трудности диагностики и лечения поражения почек у пациента с генерализованным саркоидозом, перенесшего COVID-19
________________________________________________
Lebedeva MV, Chebotareva NV, Beketov VD. Diagnostic and treatment difficulties in kidney damage in the patient with generalized sarcoidosis during COVID-19. Case report. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(6):769–771. DOI: 10.26442/00403660.2022.06.201566
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: саркоидозный тубулоинтерстициальный нефрит, генерализованный саркоидоз, новая коронавирусная инфекция
________________________________________________
The presented clinical observation reflects the difficulties of differential diagnosis of progressive kidney damage in a patient with sarcoidosis who has undergone a new coronavirus infection. The differential circle included interstitial nephritis as an exacerbation of the underlying disease, acute drug-induced kidney injury, acute glomerulonephritis. Nephrobiopsy confirmed the diagnosis of acute sarcoid tubulointerstitial nephritis with acute tubular necrosis. Timely administration of corticosteroids led to the control of the sarcoidosis process, restoration of kidney function.
Keywords: sarcoidosis tubulo-interstitial nephritis, generalized sarcoidosis, new coronavirus infection
2. Baughman RP, Lower EE. COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(2):e2021029. DOI:10.36141/svdld.v38i2.11646
3. Brito-Zerón P, Gracia-Tello B, Robles A, et al. Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis. Viruses. 2021;13(6):1000. DOI:10.3390/v13061000
4. Chebotareva N, Berns S, Berns A, et al. Acute kidney injury and mortality in coronavirus disease 2019: results from a cohort study of 1,280 patients. Kidney Res Clin Pract. 2021;40(2):241-9. DOI:10.23876/j.krcp.20.128
________________________________________________
1. Baughman RP, Lower EE, Buchanan M, et al. Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire. Sarcoidosis Vasc Diffuse Lung Dis. 2020;37(4):e2020009. DOI:10.36141/svdld.v37i4.10726
2. Baughman RP, Lower EE. COVID-19 infections in sarcoidosis: a prospective single center study of 886 sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(2):e2021029. DOI:10.36141/svdld.v38i2.11646
3. Brito-Zerón P, Gracia-Tello B, Robles A, et al. Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis. Viruses. 2021;13(6):1000. DOI:10.3390/v13061000
4. Chebotareva N, Berns S, Berns A, et al. Acute kidney injury and mortality in coronavirus disease 2019: results from a cohort study of 1,280 patients. Kidney Res Clin Pract. 2021;40(2):241-9. DOI:10.23876/j.krcp.20.128
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия
*lebedeva_m_v_2@staff.sechenov.ru
________________________________________________
Marina V. Lebedeva*, Natalia V. Chebotareva, Vladimir D. Beketov
Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
*lebedeva_m_v_2@staff.sechenov.ru